As increased activation of the CNS immune system leads to decreased production of brain-derived neurotrophic factor and other neurotrophic factors, this process, together with the production of neurotoxic proinflammatory factors such as IL-6, TNFα and IL-1β, may contribute to brain volume loss in schizophrenia. This evidence concerns the gene IL1B and schizophrenia.